Fig. 5
From: IL-32B is the predominant isoform expressed under inflammatory conditions in vitro and in COPD
Microarray analysis of IL-32 expression in cells from patients with the indicated disease. a Analysis of IL-32 gene expression in Alveolar Macrophages from healthy non-smokers (n = 24), healthy smokers (n = 34) and smokers with COPD (n = 12), non-smoker vs. COPD, p = 0.0003; non-smoker vs. smoker, p = 0.0002; smoker vs. COPD, not significant. b Analysis of IL-32 gene expression in Airway Epithelial Cells from non-smokers (n = 12), early COPD (n = 9), smokers (n = 12) and COPD (n = 6). non-smoker vs. COPD, p = 0.0156. Other comparisons are not statistically significant. c Analysis of IL-32 gene expression in Airway Epithelial Cells from normal donors (n = 28), smokers (n = 16) and asthmatic at baseline (n = 42). No significant differences observed